Arkolith/Insider Trading/RCKT/Form 4

Schwartz Jonathan David

See RemarksROCKET PHARMACEUTICALS, INC. (RCKT) · full profile →Form 4 · filed Aug 20, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$8K
Net Open-Market Flow
-$8K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 19, 2025Sell(S)805$3.00$2K222K
Aug 18, 2025Sell(S)2K$3.07$5K222K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001140361-25-032091) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML